In this episode of LATAM MedTech Insights, we explore the essential labeling and language regulations for Software as a Medical Device (SaMD) in Mexico. We unpack the specific requirements set by the national regulatory body, COFEPRIS, and highlight the critical importance of Spanish language localization for a successful market entry. We discuss a common pitfall through a case study: an innovative SaMD company faces a costly six-month delay in their COFEPRIS application. The reason? While all their documents were translated, the software's user interface, including simple menus and error messages, was left in English—a critical oversight that made their product non-compliant. This episode details how to avoid this and other regulatory hurdles. Key questions answered in this episode: - What is the single most important language requirement for medical device software in Mexico? - Which specific Mexican Official Standard (NOM) governs all labeling rules? - Does the language requirement apply to the software's user interface and error messages? - What specific information must be included in the electronic label of a SaMD? - How can a simple localization mistake lead to significant delays and costs with COFEPRIS? - Where must labeling information be placed for software that is downloaded versus distributed on physical media? - Why is treating translation as a final step a major risk for your market access strategy? At Pure Global, we specialize in streamlining global market access for MedTech companies. Our team combines local expertise with advanced AI tools to manage your entire regulatory lifecycle, from initial strategy and technical dossier submission to post-market surveillance. Let us be your local representative in Mexico and over 30 other markets. Contact us at [email protected] or visit https://pureglobal.com/ to learn more.